Jazz Pharmaceuticals (JAZZ) Capital Expenditures Growth (3y) (2013 - 2026)
Jazz Pharmaceuticals (JAZZ) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 172.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172.34% |
| Dec 31, 2025 | -469.71% |
| Sep 30, 2025 | 253.91% |
| Jun 30, 2025 | -15.05% |
| Dec 31, 2024 | 39.57% |
| Sep 30, 2024 | -14.89% |
| Jun 30, 2024 | 210.78% |
| Mar 31, 2024 | 203.84% |
| Dec 31, 2023 | -35.34% |
| Sep 30, 2023 | 26.92% |
| Jun 30, 2023 | 4.23% |
| Mar 31, 2023 | 112.30% |
| Dec 31, 2022 | 32.20% |
| Sep 30, 2022 | 20.38% |
| Jun 30, 2022 | -61.17% |
| Mar 31, 2022 | -31.96% |
| Dec 31, 2021 | -13.35% |
| Sep 30, 2021 | 1.00% |
| Jun 30, 2021 | 26.76% |
| Mar 31, 2021 | -26.45% |